0114 232 9292 connect@medilink.co.uk

Medilink member receives the prestigious Queen’s Award for Enterprise

Medilink member Xiros have recently been awarded the UK’s highest accolade for business success: the Queen’s Award for Enterprise.

Xiros have received the award in the International Trade category, in recognition of their outstanding overseas sales growth over the last three years.

Roland Henney, a Xiros Director, said: “This is a tremendous achievement, which has been made possible by the continuous hard work and dedication of everyone at Xiros. Our company’s ethos is to make a positive difference to the world and the people in it, and I am deeply proud that the devices we manufacture are being used to relieve patients of debilitating injuries in over fifty countries globally. To have been recognized in such a way for the good work that we do is truly humbling.”

This is the second time Xiros has been awarded this prestigious accolade; the first being in 2008, again in the category of International Trade. This further success demonstrates their continued development and business expansion, with more than fifty new employees having been recruited since the first award, and further appointments planned in the near future.

The 2016 Queen’s Award follows a number of other outstanding achievements for Xiros, including a five star grading in the British Safety Council’s Occupational Health and Safety Audit, an Investors in People Health and Wellbeing Award, and being shortlisted for the Investors in People Excellence in Reward and Recognition Award 2016. The company, which is proud to have held the prestigious Investors in People Standard since 2000, has also recently achieved Investors in People Gold Standard Accreditation: a distinction held by fewer than 600 companies worldwide.

The Queen’s Awards for Enterprise were announced on 21st April 2016, in recognition of Her Majesty the Queen’s birthday. Xiros is delighted and honoured to be one of the select businesses recognized as winners.

Comments are closed.